Leadership, Partnerships August 04, 2022 RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
Site Expansion June 08, 2022 RoslinCT continues its growth plans by expanding its operations at Edinburgh Technopole
Leadership February 02, 2022 RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture
Cell Therapy, Investment, Partnerships January 11, 2022 GHO Capital invests in RoslinCT, a leading cell therapy CDMO
Facilities, Site Expansion February 05, 2021 RoslinCT announces the establishment of a Cell and Gene Training Academy